Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
British Journal of Clinical Pharmacology|February 1, 1989
Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP)J A Barnett, D E Brenner, P J Creaven, et al.Cancer Research|October 1, 1984
Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodentsM P Kung, Y K Ho, D Lalka, et al.European Journal of Clinical Pharmacology|January 1, 1983
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugsD L Goolkasian, R L Slaughter, D J Edwards, et al.Journal of Pharmaceutical Sciences|July 1, 1977
Absorption kinetics of procainamide in humansC V Manion, D Lalka, D T Baer, et al.Clinical Pharmacokinetics|November 1, 1986
Free drug concentration monitoring in clinical practice. Rationale and current statusC K Svensson, M N Woodruff, J G Baxter, et al.Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flowC K Svensson, J C Cumella, M Tronolone, et al.Therapeutic Drug Monitoring|October 16, 1999
High-dose omeprazole: use of a multiple-dose study design to assess bioequivalence and accuracy of CYP2C19 phenotypingP Kovacs, D J Edwards, D Lalka, et al.The Journal of Laboratory and Clinical Medicine|August 1, 1978
Comparison of screening methods for determination of N4-acetyltransferase capacity (acetylator phenotype) in outbred rabbit strainsP du Souich, D Lalka, A J McLean, et al.Journal of Pharmaceutical Sciences|April 1, 1986
Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purityR Heintz, C K Svensson, K Stoeckel, et al.Clinical Pharmacology and Therapeutics|February 1, 1979
Mechanisms of nonlinear disposition kinetics of sulfamethazineP du Souich, D Lalka, R Slaughter, et al.Pageof 5